$TMGI
Marquie Group, Inc.

2023 Q4 Form 10-Q Financial Statement

#000168316823007339 Filed on October 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $166.8K $77.54K $103.9K
YoY Change -8.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $220.00 $230.00 $230.00
YoY Change -71.79% -40.87%
% of Gross Profit
Operating Expenses $166.8K $77.54K $103.9K
YoY Change 88.04% -22.01%
Operating Profit -$166.8K -$77.54K
YoY Change 88.04% -22.01%
Interest Expense $135.3K $112.6K $435.1K
YoY Change 69.33% 179.84%
% of Operating Profit
Other Income/Expense, Net $32.65K $430.6K
YoY Change -140.85% 970.25%
Pretax Income -$134.1K $353.1K $331.2K
YoY Change -108.21% -352.81%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings -$134.1K $353.1K $331.2K
YoY Change -20.46% -352.81%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 756.6M shares 884.3M shares 756.6M shares
Diluted Shares Outstanding 427.6M shares 756.6M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.430K $120.00 $0.00
YoY Change 211.54%
Cash & Equivalents $2.433K $117.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $483.00 $699.00 $929.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.433K $117.00 $0.00
YoY Change 210.33% -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment $480.00 $700.00 $930.00
YoY Change -65.47%
Goodwill
YoY Change
Intangibles $10.37K $10.37K $10.37K
YoY Change 0.0% 0.0% 0.0%
Long-Term Investments $6.200M $6.200M $6.200M
YoY Change 0.0%
Other Assets $6.239M $6.239M $6.240M
YoY Change 0.29% 49688.87%
Total Long-Term Assets $6.239M $6.239M $6.240M
YoY Change 0.29% 51281.96% 49688.87%
TOTAL ASSETS
Total Short-Term Assets $2.433K $117.00 $0.00
Total Long-Term Assets $6.239M $6.239M $6.240M
Total Assets $6.242M $6.239M $6.240M
YoY Change 0.32% 51282.92% 48324.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $70.00K $67.64K $50.66K
YoY Change -1.85% 21.16% 43.1%
Accrued Expenses $2.010M $1.872M $1.724M
YoY Change 40.05%
Deferred Revenue
YoY Change
Short-Term Debt $3.567M $3.581M $3.556M
YoY Change 2.79%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.017M $6.013M $6.367M
YoY Change -22.95% 3.56% 12.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.017M $6.013M $6.367M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $6.017M $6.013M $6.367M
YoY Change -22.95% 3.56% 12.33%
SHAREHOLDERS EQUITY
Retained Earnings -$14.48M -$14.34M -$14.70M
YoY Change -10.39% -10.44% -7.43%
Common Stock $115.4K $75.66K $75.66K
YoY Change 52.57% 4567.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $224.8K $226.1K -$127.0K
YoY Change
Total Liabilities & Shareholders Equity $6.242M $6.239M $6.240M
YoY Change 0.32% 51282.92% 48324.84%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$134.1K $353.1K $331.2K
YoY Change -20.46% -352.81%
Depreciation, Depletion And Amortization $220.00 $230.00 $230.00
YoY Change -71.79% -40.87%
Cash From Operating Activities -$106.2K -$337.00 -$74.11K
YoY Change 122.81% -98.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$5.000K
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 -$5.000K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 108.5K $454.00 79.06K
YoY Change 89.24% -98.28%
NET CHANGE
Cash From Operating Activities -106.2K -$337.00 -74.11K
Cash From Investing Activities 0.000 $0.00 -5.000K
Cash From Financing Activities 108.5K $454.00 79.06K
Net Change In Cash 2.320K $117.00 -50.00
YoY Change 439.53% -133.14%
FREE CASH FLOW
Cash From Operating Activities -$106.2K -$337.00 -$74.11K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001434601
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2022Q3 us-gaap Stock Option Down Round Feature Increase Decrease In Equity Amount1
StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount1
usd
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-08-31
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
000-54163
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
The Marquie Group, Inc.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2091212
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
7901 4th ST N
CY2023Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4000
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
St. Petersburg
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33702
CY2023Q3 dei City Area Code
CityAreaCode
800
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
351-3021
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
756612000 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
117 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
117 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
0 usd
CY2023Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
6200000 usd
CY2023Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
6200000 usd
CY2023Q3 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
28247 usd
CY2023Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
28247 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20949 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20719 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
699 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
929 usd
CY2023Q3 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2023Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6239311 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6239541 usd
CY2023Q3 us-gaap Assets
Assets
6239428 usd
CY2023Q2 us-gaap Assets
Assets
6239541 usd
CY2023Q3 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2023Q2 us-gaap Bank Overdrafts
BankOverdrafts
46 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
67639 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
50664 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
666491 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
578017 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1205917 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1145917 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
42669 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
66794 usd
CY2023Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1489263 usd
CY2023Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1465138 usd
CY2023Q3 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2091272 usd
CY2023Q2 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2090772 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
492775 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1035998 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6013357 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6366552 usd
CY2023Q3 us-gaap Liabilities
Liabilities
6013357 usd
CY2023Q2 us-gaap Liabilities
Liabilities
6366552 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
756612000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
756612000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
756612000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
756612000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
75663 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
75663 usd
CY2023Q3 TMGI Common Stock Payable
CommonStockPayable
8460 usd
CY2023Q2 TMGI Common Stock Payable
CommonStockPayable
8460 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14486896 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14486896 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14344948 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14698030 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
226071 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-127011 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6239428 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6239541 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
60000 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
60000 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
16976 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
38121 usd
CY2023Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
567 usd
CY2022Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
1305 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
77543 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
99426 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-77543 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-99426 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
543223 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
41194 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
24125 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14878 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
112598 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
53208 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
430625 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12014 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
353082 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-111440 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
353082 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-111440 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
756612000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
756612000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16192332 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16192332 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-127011 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
353082 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
226071 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5654677 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-111440 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5766117 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
353082 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-111440 usd
CY2023Q3 us-gaap Depreciation
Depreciation
230 usd
CY2022Q3 us-gaap Depreciation
Depreciation
389 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
543223 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
41194 usd
CY2023Q3 TMGI Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
24125 usd
CY2022Q3 TMGI Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
14878 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16975 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
20421 usd
CY2023Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
88474 usd
CY2022Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
34451 usd
CY2023Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
60000 usd
CY2022Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
55700 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-337 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26795 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q3 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-46 usd
CY2022Q3 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
62 usd
CY2023Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2022Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
38880 usd
CY2023Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
CY2022Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
12500 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
500 usd
CY2022Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
454 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26442 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
117 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-353 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
353 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q3 TMGI Initial Derivative Liability Charged To Debt Discounts
InitialDerivativeLiabilityChargedToDebtDiscounts
0 usd
CY2022Q3 TMGI Initial Derivative Liability Charged To Debt Discounts
InitialDerivativeLiabilityChargedToDebtDiscounts
38880 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
21648 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
21648 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20949 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20719 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
699 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
929 usd
CY2023Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
CY2023Q3 us-gaap Depreciation
Depreciation
230 usd
CY2022Q3 us-gaap Depreciation
Depreciation
389 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1205917 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1145917 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1145917 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
CY2023Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
60000 usd
CY2023 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
240000 usd
CY2023Q3 TMGI Payments To Consultants
PaymentsToConsultants
0 usd
CY2023 TMGI Payments To Consultants
PaymentsToConsultants
-20300 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1205917 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1145917 usd
CY2023Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1489263 usd
CY2023Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1465138 usd
CY2023Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1489263 usd
CY2023Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1465138 usd
CY2023Q3 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
0 usd
CY2023Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
0 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
1531932 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1531932 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-42669 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-66794 usd
CY2023Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1489263 usd
CY2023Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1465138 usd
CY2023Q3 TMGI Notes Payable Related Parties
NotesPayableRelatedParties
2091272 usd
CY2023Q2 TMGI Notes Payable Related Parties
NotesPayableRelatedParties
2090772 usd
CY2023Q3 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2091272 usd
CY2023Q2 TMGI Notes Payable To Related Parties Current
NotesPayableToRelatedPartiesCurrent
2090772 usd
CY2023Q3 TMGI Notes Payable To Related Parties Noncurrent
NotesPayableToRelatedPartiesNoncurrent
0 usd
CY2023Q2 TMGI Notes Payable To Related Parties Noncurrent
NotesPayableToRelatedPartiesNoncurrent
0 usd
CY2023Q3 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
603517 usd
CY2023Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
492775 usd
CY2023Q2 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
603517 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1035998 usd
CY2023Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
492775 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1035998 usd
CY2021 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4304842 shares
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
835050 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1445042 usd
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 1,000 reverse split
CY2023Q3 TMGI Working Capital
WorkingCapital
6013240 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14344948 usd

Files In Submission

Name View Source Status
0001683168-23-007339-index-headers.html Edgar Link pending
0001683168-23-007339-index.html Edgar Link pending
0001683168-23-007339.txt Edgar Link pending
0001683168-23-007339-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
marquie_ex3101.htm Edgar Link pending
marquie_ex3201.htm Edgar Link pending
marquie_i10q-083123.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
marquie_i10q-083123_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmgi-20230831.xsd Edgar Link pending
tmgi-20230831_def.xml Edgar Link unprocessable
tmgi-20230831_cal.xml Edgar Link unprocessable
tmgi-20230831_lab.xml Edgar Link unprocessable
tmgi-20230831_pre.xml Edgar Link unprocessable